Article contents
Amitriptyline and Perphenazine in Depressive Illness a Controlled Trial
Published online by Cambridge University Press: 29 January 2018
Extract
This paper describes a “double-blind” trial comparing ‘Triptafen’ tablets—each containing amitriptyline hydrochloride 25 mg. and perphenazine 2 mg.—with a matching placebo in the treatment of depressive illness.
- Type
- Research Article
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1967
References
Medical Research Council (1965). “Clinical trial of the treatment of depressive illness.” Report by the Clinical Psychiatry Committee. Brit. med. J., i, 881–886.Google Scholar
Ernst, E. M. (1963). “Treatment of anxiety and depression in general practice.” Penn. med. J., 66, 43–45.Google Scholar
Martins, J. K. (1966). “Combined amitriptyline-perphenazine (Etrafon) compared with chlordiazepoxide hydrochloride: a double-blind, crossover study.” Curr. Therap. Res., 8, 17–22.Google Scholar
Mattey, W. E. (1963). “Combination therapy for relief of anxiety and depression.” Ibid., 5, 310–318.Google Scholar
Smith, M. E. (1963). “Perphenazine and amitriptyline as adjuncts to psychotherapy.” Amer. J. Psychiat., 120, 76–77.Google Scholar
- 9
- Cited by
eLetters
No eLetters have been published for this article.